West Virginia · 2025 Regular Session · Bill
HB 3344: Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine
Passed one chamber Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 3344 is a bill introduced in the West Virginia House on March 13, 2025. According to its official title, it concerns: Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine. Primary sponsor: Evan Worrell (Republican). It lists 3 additional sponsors. Most recent recorded action (April 11, 2025): Laid over on 3rd reading 4/11/2025.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Republican 4
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Evan Worrell | Primary sponsor | Republican | House | 23 |
| Ryan Browning | Co-sponsor | Republican | House | 28 |
| Adam Burkhammer | Co-sponsor | Republican | House | 64 |
| Mike Hite | Co-sponsor | Republican | House | 92 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Laid over on 3rd reading 4/11/2025
- Deferred until foot of 2nd reading
- On 3rd reading
- Committee amendment adopted (Voice vote)
- Read 2nd time
- On 2nd reading
- Read 1st time
- Immediate consideration
- Reported do pass
- To Finance
- Reported do pass, with amendment, but first to Finance
- To Health and Human Resources
Showing 12 most recent of 28 actions. Full history